BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8259536)

  • 1. Venous thromboembolism and high grade gliomas.
    Dhami MS; Bona RD; Calogero JA; Hellman RM
    Thromb Haemost; 1993 Sep; 70(3):393-6. PubMed ID: 8259536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism and survival in patients with high-grade glioma.
    Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
    Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of thromboembolism in patients with central nervous system lymphoma.
    Goldschmidt N; Linetsky E; Shalom E; Varon D; Siegal T
    Cancer; 2003 Sep; 98(6):1239-42. PubMed ID: 12973848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis.
    Gerber DE; Segal JB; Salhotra A; Olivi A; Grossman SA; Streiff MB
    Cancer; 2007 Jan; 109(2):300-5. PubMed ID: 17154163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism in pediatric patients with brain tumors.
    Tabori U; Beni-Adani L; Dvir R; Burstein Y; Feldman Z; Pessach I; Rechavi G; Constantini S; Toren A
    Pediatr Blood Cancer; 2004 Nov; 43(6):633-6. PubMed ID: 15390288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
    Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
    Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant venous thromboembolism after gynecologic surgery.
    Schorge JO; Goldhaber SZ; Duska LR; Goodman A; Feldman S
    J Reprod Med; 1999 Aug; 44(8):669-73. PubMed ID: 10483535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
    Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in cancer patients in Christchurch, 1995-1999.
    Joung S; Robinson B
    N Z Med J; 2002 Jun; 115(1155):257-60. PubMed ID: 12117159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism after retrieval of inferior vena cava filters.
    Yavuz K; Geyik S; Hoppe H; Kolbeck KJ; Kaufman JA
    J Vasc Interv Radiol; 2008 Apr; 19(4):504-508. PubMed ID: 18375293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
    Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
    Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.
    Semrad TJ; O'Donnell R; Wun T; Chew H; Harvey D; Zhou H; White RH
    J Neurosurg; 2007 Apr; 106(4):601-8. PubMed ID: 17432710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
    Otten HM; Mathijssen J; ten Cate H; Soesan M; Inghels M; Richel DJ; Prins MH
    Arch Intern Med; 2004 Jan; 164(2):190-4. PubMed ID: 14744843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
    Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
    Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.
    Cook D; Attia J; Weaver B; McDonald E; Meade M; Crowther M
    J Crit Care; 2000 Dec; 15(4):127-32. PubMed ID: 11138871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.